PD1-LAG3 Bispecific antibody (Sutro Biopharma)

N/A

Report date: 2022/08/26 14:14:14

Base Information

Drug NamePD1-LAG3 Bispecific antibody (Sutro Biopharma)

Drug Alias NamePD1-LAG3 bsAb(Sutro Biopharma)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionLymphocyte activation gene 3 protein modulatorsProgrammed cell death protein 1 modulators

TargetsLymphocyte activation gene 3 proteinProgrammed cell death protein 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSutro Biopharma Inc

China Registration ClassN/A

Develop Information

Active CompaniesSutro Biopharma Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A